Monique Yoakim-Turk, PhD

Partner, Technology Development Fund

Monique joined the Technology & Innovation Development Office of Boston Children’s Hospital in 2000. In In 2009, Monique launched the Boston Children’s Technology Development Fund (TDF) – an academic investment fund – and has since led the fund through nine funding cycles. For TDF, she designed and implemented evaluation processes, formed an advisory board of industry leaders in product development, and established and managed collaborations with development partners and CROs. Since 2009, Boston Children’s has committed $7.8M to TDF, which has generated $26M of follow-on funding, 7 startups which collectively raised $80M in seed funding and 10 licenses to date.

In her previous role as Director of Pediatric Initiatives at TIDO, she led development of tools and processes to advance clinical and research innovations for the pediatric market. Prior to that, as Senior Licensing Manager, Monique handled technologies in the therapeutic, diagnostic and medical device arenas, closed significant deals in licensing and sponsored research and established creative collaborations with industry partners.

Prior to Boston Children’s, Monique was a post-doctoral fellow at the Beth Israel Deaconess Medical Center in the laboratory of Dr. Benjamin Neel, where she studied the regulation of cytokine receptors by the tyrosine phosphatase SHP1. She holds a PhD in biochemistry from the Tufts University, Sackler School of Graduate Biomedical Sciences. In the laboratory of Brian Schaffhausen, PhD, her doctoral thesis focused on the regulation of the PI3-Kinase by Polyomavirus middle T antigen and the proto-oncogene c-src. Monique has authored and co-authored 9 peer reviewed publications. She also holds a BS and an MS in biology from the University of Massachusetts.